Precision medicine
About us
We are building the next-generation of pain killers
With over 25 years in research pain and pharmaceutical industry we are dedicated to researching new treatments for serious diseases in areas with significant unmet medical needs—and to ensuring these solutions reach the patients who need them most.
Our vision
At Dolinnov, our vision is to revolutionize patients' lives and transform the landscape of pain management through cutting-edge research and innovation.
Our ambition is to pioneer the first L-ASO therapies for severe and unbearable chronic pain, currently reserved for ultra-rare diseases.
Our operating team
Our scientific advisory board
An innovation-driven team
What immediately inspired me to join this project was its groundbreaking approach to targeting this mechanism—a causal and 'circuit-breaking' strategy for pain management. Combined with the exceptional quality of the underlying science, it redefines treatment paradigms, effectively addressing the primary barriers to patient care.
It is the extraordinary motivation of a researcher to transform a groundbreaking academic discovery from my thesis into a preclinical reality, with the goal of revolutionizing patient care and advancing the frontiers of medicine.
Dolinnov is a unique opportunity to convert a high-level academic scientific project into a groundbreaking enterprise. I am committed to dedicating my full energy to turning this project into a clinical reality that will make a difference for patients.
Investing in Dolinnov is above all about supporting a highly mature, scientific disruptive project with the potential to deliver game-changing treatment solutions. It also means placing trust in a strong and dedicated team capable of making this vision a clinical reality.
Dolinnov is a unique opportunity to convert a high-level academic scientific project into a groundbreaking enterprise. I am committed to dedicating my full energy to turning this project into a clinical reality that will make a difference for patients.
It is the extraordinary motivation of a researcher to transform a groundbreaking academic discovery from my thesis into a preclinical reality, with the goal of revolutionizing patient care and advancing the frontiers of medicine.
What immediately inspired me to join this project was its groundbreaking approach to targeting this mechanism—a causal and 'circuit-breaking' strategy for pain management. Combined with the exceptional quality of the underlying science, it redefines treatment paradigms, effectively addressing the primary barriers to patient care.
Investing in Dolinnov is above all about supporting a highly mature, scientific disruptive project with the potential to deliver game-changing treatment solutions. It also means placing trust in a strong and dedicated team capable of making this vision a clinical reality.
A patient driven Biotech
Through close collaboration with patient associations, we ensure our innovations address real needs and improve lives.
Uniting with shared mission
We unite patients, investors, clinicians, and experts to tackle this challenge
Impact-Driven Investors
First investors back a project focused on innovation and positive change for patients.
A Multidisciplinary Team Driving Innovation
Experienced team driving the project to new heights.
A New Paradigm in Pain Management
We are transforming pain treatment with a safer, non-opioid solution.
.svg)
already deployed on this project
Partners supporting the project
Design with by the gang